StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$143.28−0.75 (-0.52%)

Close on Nov 17, 2026Market cap $19.23BP/E –Yield –

Guardant Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Guardant Health's revenue for the twelve months ending Jun 30, 2026 was $1.18B, up 42.7% year over year. For fiscal 2025 it was $982.02M, up 32.9% from the year before. The highest annual figure on record is $982.02M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$982.02M+32.9%
FY2024Dec 31, 2024$739.02M+31.0%
FY2023Dec 31, 2023$563.95M+25.5%
FY2022Dec 31, 2022$449.54M+20.3%
FY2021Dec 31, 2021$373.65M+30.3%
FY2020Dec 31, 2020$286.73M+33.8%
FY2019Dec 31, 2019$214.38M+136.5%
FY2018Dec 31, 2018$90.64M+81.9%
FY2017Dec 31, 2017$49.84M+97.4%
FY2016Dec 31, 2016$25.25M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$334.98M+44.3%
Q1 FY2026Mar 31, 2026$301.67M+48.3%
Q4 FY2025Dec 31, 2025$281.27M+39.4%
Q3 FY2025Sep 30, 2025$265.20M+38.5%
Q2 FY2025Jun 30, 2025$232.09M+30.9%
Q1 FY2025Mar 31, 2025$203.47M+20.8%
Q4 FY2024Dec 31, 2024$201.81M+30.2%
Q3 FY2024Sep 30, 2024$191.48M+33.9%
Q2 FY2024Jun 30, 2024$177.24M+29.2%
Q1 FY2024Mar 31, 2024$168.49M+30.9%
Q4 FY2023Dec 31, 2023$155.05M+22.2%
Q3 FY2023Sep 30, 2023$143.03M+21.8%
Q2 FY2023Jun 30, 2023$137.15M+25.7%
Q1 FY2023Mar 31, 2023$128.71M+33.9%
Q4 FY2022Dec 31, 2022$126.89M+17.4%
Q3 FY2022Sep 30, 2022$117.40M+23.9%
Q2 FY2022Jun 30, 2022$109.14M+18.5%
Q1 FY2022Mar 31, 2022$96.10M+22.2%
Q4 FY2021Dec 31, 2021$108.11M+38.0%
Q3 FY2021Sep 30, 2021$94.78M+27.1%
Q2 FY2021Jun 30, 2021$92.10M+38.8%
Q1 FY2021Mar 31, 2021$78.67M+16.5%
Q4 FY2020Dec 31, 2020$78.32M+24.5%
Q3 FY2020Sep 30, 2020$74.57M+22.5%
Q2 FY2020Jun 30, 2020$66.34M+22.9%
Q1 FY2020Mar 31, 2020$67.51M+84.2%
Q4 FY2019Dec 31, 2019$62.90M+91.3%
Q3 FY2019Sep 30, 2019$60.85M+180.5%
Q2 FY2019Jun 30, 2019$53.98M+178.5%
Q1 FY2019Mar 31, 2019$36.66M+119.6%
Q4 FY2018Dec 31, 2018$32.87M+64.3%
Q3 FY2018Sep 30, 2018$21.69M+94.9%
Q2 FY2018Jun 30, 2018$19.38M–
Q1 FY2018Mar 31, 2018$16.69M–
Q4 FY2017Dec 31, 2017$20.00M–
Q3 FY2017Sep 30, 2017$11.13M–

More Guardant Health figures

See a number that looks wrong?